(Q42488442)

1 November 2017

Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo (English)

1 reference

1 November 2017

hepatocellular carcinoma

1 reference

7

1 reference

1 November 2017

8

Peter Malfertheiner

1 reference

1 November 2017

Jun Yu

1

1 reference

1 November 2017

Liang Qiao

2

1 reference

1 November 2017

Lars Zimmermann

3

1 reference

1 November 2017

Matthias P A Ebert

4

1 reference

1 November 2017

Hongxia Zhang

5

1 reference

1 November 2017

Wendy Lin

6

1 reference

1 November 2017

Geoffrey C Farrell

9

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

1 November 2017

1 reference

1 November 2017

43

1 reference

1 November 2017

1

1 reference

1 November 2017

134-143

1 reference

Effect of ligand of peroxisome proliferator-activated receptor gamma on the biological characters of hepatic stellate cells

1 November 2017

1 reference

PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function

21 January 2018

1 reference

7 January 2021

The organization, promoter analysis, and expression of the human PPARgamma gene

1 reference

7 January 2021

Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines

1 reference

7 January 2021

Differentiation and reversal of malignant changes in colon cancer through PPARgamma

1 reference

7 January 2021

Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice

1 reference

7 January 2021

Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J-APCMin/+ mice

1 reference

7 January 2021

Activators of the nuclear receptor PPARgamma enhance colon polyp formation

1 reference

7 January 2021

Surfing the p53 network

1 reference

7 January 2021

1 reference

7 January 2021

Decreased peroxisome proliferator-activated receptor gamma gene expression is correlated with poor prognosis in patients with esophageal cancer

1 reference

7 January 2021

Expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma and levels of prostaglandin E2 and 15-deoxy-delta12,14-prostaglandin J2 in human breast cancer and metastasis

1 reference

7 January 2021

Clinical implication of expression of cyclooxygenase-2 and peroxisome proliferator activated-receptor gamma in epithelial ovarian tumours

1 reference

7 January 2021

APC-dependent suppression of colon carcinogenesis by PPARgamma

1 reference

7 January 2021

Lessons from hereditary colorectal cancer

1 reference

7 January 2021

Loss of the peroxisome proliferation-activated receptor gamma (PPARgamma ) does not affect mammary development and propensity for tumor formation but leads to reduced fertility

1 reference

7 January 2021

Peroxisome proliferator-activated receptor gamma ligand-induced growth inhibition of human hepatocellular carcinoma

1 reference

7 January 2021

Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation

1 reference

7 January 2021

Iron chelation-induced senescence-like growth arrest in hepatocyte cell lines: association of transforming growth factor beta1 (TGF-beta1)-mediated p27Kip1 expression.

1 reference

7 January 2021

p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest

1 reference

7 January 2021

The role of senescence and immortalization in carcinogenesis

1 reference

7 January 2021

Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53.

1 reference

7 January 2021

Sodium butyrate induces NIH3T3 cells to senescence-like state and enhances promoter activity of p21WAF/CIP1 in p53-independent manner

1 reference

7 January 2021

PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A.

1 reference

7 January 2021

Peroxisome proliferator-activated receptor-gamma activation inhibits tumor progression in non-small-cell lung cancer.

1 reference

7 January 2021

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

1 reference

7 January 2021

Peroxisome proliferator-activated receptor gamma agonists promote TRAIL-induced apoptosis by reducing survivin levels via cyclin D3 repression and cell cycle arrest.

1 reference

7 January 2021

Expression of HBx and COX-2 in chronic hepatitis B, cirrhosis and hepatocellular carcinoma: implication of HBx in upregulation of COX-2.

1 reference

7 January 2021

Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells

1 reference

7 January 2021

Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p300.

1 reference

7 January 2021

Inhibitory effects of troglitazone, a peroxisome proliferator-activated receptor gamma ligand, in rat tongue carcinogenesis initiated with 4-nitroquinoline 1-oxide

1 reference

7 January 2021

Effect of PPAR activators on cytokine-stimulated cyclooxygenase-2 expression in human colorectal carcinoma cells

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20994

1 reference

1 November 2017

1 reference